Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery
…, GS Dasanayake, ME Gorniak, MC Pride… - Nature …, 2023 - nature.com
Polymeric nanoparticles (NPs) are a promising platform for medical applications in drug
delivery. However, their use as drug carriers is limited by biological (eg, immunological) barriers …
delivery. However, their use as drug carriers is limited by biological (eg, immunological) barriers …
Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis
M Pride, P Seubert, M Grundman, M Hagen… - Neurodegenerative …, 2008 - karger.com
Background: In a phase 2a clinical trial of AN1792 (Study 201), a potential immunotherapeutic
agent for use in Alzheimer’s disease (AD), approximately 6% of the treated AD patients (…
agent for use in Alzheimer’s disease (AD), approximately 6% of the treated AD patients (…
[HTML][HTML] Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults
…, H Smith, T Mellelieu, MW Pride… - … England Journal of …, 2015 - Mass Medical Soc
Background Pneumococcal polysaccharide conjugate vaccines prevent pneumococcal
disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in …
disease in infants, but their efficacy against pneumococcal community-acquired pneumonia in …
[HTML][HTML] BNT162b vaccines protect rhesus macaques from SARS-CoV-2
…, M Pride, IL Scully, T Ciolino, J Obregon, M Gazi… - Nature, 2021 - nature.com
A safe and effective vaccine against COVID-19 is urgently needed in quantities that are
sufficient to immunize large populations. Here we report the preclinical development of two …
sufficient to immunize large populations. Here we report the preclinical development of two …
Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome
…, B Onaga, MC Pride, RL Coulson, M Yang… - Neurobiology of learning …, 2019 - Elsevier
Prader-Willi syndrome (PWS) is an imprinted neurodevelopmental disease caused by a loss
of paternal genes on chromosome 15q11-q13. It is characterized by cognitive impairments, …
of paternal genes on chromosome 15q11-q13. It is characterized by cognitive impairments, …
Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children
BD Forrest, MW Pride, AJ Dunning… - Clinical and vaccine …, 2008 - Am Soc Microbiol
The highly sensitive gamma interferon (IFN-γ) enzyme-linked immunosorbent spot (ELISPOT)
assay permits the investigation of the role of cell-mediated immunity (CMI) in the protection …
assay permits the investigation of the role of cell-mediated immunity (CMI) in the protection …
Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
…, L Miller, I DaSilva, M Mack, XJ Zhao, MW Pride… - Vaccine, 2010 - Elsevier
Factor H binding proteins (fHBP), are bacterial surface proteins currently undergoing human
clinical trials as candidate serogroup B Neisseria meningitidis (MnB) vaccines. fHBP protein …
clinical trials as candidate serogroup B Neisseria meningitidis (MnB) vaccines. fHBP protein …
Germline Chd8 haploinsufficiency alters brain development in mouse
…, MA Riyadh, TW Stradleigh, MC Pride… - Nature …, 2017 - nature.com
The chromatin remodeling gene CHD8 represents a central node in neurodevelopmental
gene networks implicated in autism. We examined the impact of germline heterozygous …
gene networks implicated in autism. We examined the impact of germline heterozygous …
[HTML][HTML] GABAB receptor agonist R-baclofen reverses social deficits and reduces repetitive behavior in two mouse models of autism
JL Silverman, MC Pride, JE Hayes… - …, 2015 - nature.com
Autism spectrum disorder (ASD) is diagnosed by two core behavioral criteria, unusual
reciprocal social interactions and communication, and stereotyped, repetitive behaviors with …
reciprocal social interactions and communication, and stereotyped, repetitive behaviors with …
Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged≥ 18 years
…, Y Peng, L Moyer, MW Pride… - Clinical infectious …, 2022 - academic.oup.com
… Michael W Pride , Michael W Pride … Brandon Essink, Charu Sabharwal, Kevin Cannon,
Robert Frenck, Himal Lal, Xia Xu, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Michael W Pride, …
Robert Frenck, Himal Lal, Xia Xu, Vani Sundaraiyer, Yahong Peng, Lisa Moyer, Michael W Pride, …